Makers Laboratories Limited (BOM:506919)

Market Cap	924.00M +2.4%
Revenue (ttm)	1.49B +18.1%
Net Income	34.19M -61.6%
EPS	5.79 -61.6%
Shares Out	5.90M
PE Ratio	27.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,187
Open	156.10
Previous Close	156.10
Day's Range	156.10 - 159.85
52-Week Range	109.00 - 186.70
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About Makers Laboratories

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, dig...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 114
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506919

Financial Performance

In fiscal year 2026, Makers Laboratories's revenue was 1.41 billion, an increase of 16.30% compared to the previous year's 1.21 billion. Earnings were 23.51 million, a decrease of -68.61%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error